Principal Investigator:
Liudmila Cebotaru, M.D., J.D.
Department:
Medicine
Physiology
Research in the Liudmila Cebotaru Lab studies cystic fibrosis transmembrane conductance regulator (CFTR) mutants. We also investigate corrector molecules that are currently in clinical trials to get a better understanding of their mechanism of action. A major focus of our research is on developing more efficient gene therapy vectors with the ultimate goal of developing a gene therapy for cystic fibrosis.
Research Areas: cell biology, cystic fibrosis, kidney diseases, gene therapy, corrector molecules